Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Health Policy
AMA Delegates and Oncologists Balk at ICD-10 Implementation
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
March 2012, Vol 3, No 2
New Orleans, LA—According to the American Medical Association (AMA) and many oncologists, the
International Classification of Diseases, Tenth Revision (ICD-10)
diagnostic coding system will be a needless and expensive burden to oncology practices, without enhancing patient care.
Read Article
Americans Willing to Pay Hundreds of Dollars Out of Pocket for Cancer Risk Tests
By
Rosemary Frei, MSc
Health Policy
,
Policies & Guidelines
February 2012, Vol 3, No 1
American adults would be willing to pay a median of $263 for a perfect prostate cancer prediction test and $232 for a perfect breast cancer prediction test, according to a recent survey (Neumann PJ, et al. Health Econ. 2012;21:238-251).
Read Article
Direct-to-Consumer Genetic Testing: Concerns Trump Benefits at This Point
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
February 2012, Vol 3, No 1
Miami, FL—Direct-to-consumer (DTC) marketing of genetic tests represents personalized medicine in evolution. High-throughput genetic technologies have made it possible to evaluate individuals at a relatively affordable price, but a number of technologic, social, regulatory, and ethical issues must first be settled before DTC genetic testing takes personalized medicine to new heights.
Read Article
Paying for Quality: Increasing Shift Toward Value-Based Healthcare
Health Policy
,
Policies & Guidelines
February 2012, Vol 3, No 1
On November 30, 2011, the Office of the Inspector General (OIG) of the US Department of Health and Human Services issued an advisory opinion (No. 11-18) to the web-based physician practice service provider athenahealth, tacitly approving the company’s new online service athenaCoordinator.
Read Article
Medical Staff Members Spend Many Hours Dealing with Insurance Companies
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
December 2011, Vol 2, No 7
Medical practices in the United States spend much more money and time dealing with third-party payers than do Canadian practices, according to a recent report (Morra D, et al. Health Aff. 2011;30:1443-1450).
Read Article
GPCI, or “GYPSY”: Calculated or Covert Cuts to Oncology Reimbursement
By
Robert Gamble
Health Policy
,
Policies & Guidelines
December 2011, Vol 2, No 7
Read Article
Recent Ruling on Genetic Patents Leaves Many Questions
By
Rosemary Frei, MSc
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
On July 29, 2011, a 3-judge panel from the US Court of Appeals for the Federal Circuit invalidated some patents held by Myriad Genetics and the University of Utah Research Foundation for methods of analyzing individuals’ gene sequences for the presence of BRCA1 and BRCA2 mutations, but upheld other related patents in a reversal of a lower court ruling.
Read Article
AACR Urges Congress to Increase Funding for the NIH and NCI
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
In September 2011, the American Association of Cancer Research (AACR) issued a new report, “AACR Cancer Progress Report 2011” on the current state of cancer research and the implications of recent cuts in funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).
Read Article
US Preventive Services Task Force and the Future of Prostate Cancer Screening
By
Ross D. Margulies, JD, MPH
;
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
The decision this month (October 2011) by the US Preventive Services Task Force (USPSTF) to recommend against a prostate-specific antigen (PSA)-based screening for prostate cancer in healthy men
1
has caused quite a stir both in and outside of medical circles, reminding many people of the task force’s 2009 recommendation against routine breast cancer screenings for women under age 50 years.
Read Article
Accountable Care Organizations: Implications for Cancer-Related Quality Care and Spending
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
August 2011, Vol 2, No 5
ACOs are believed to hold the potential for addressing variation in quality and costs of cancer care, but their impact will depend on buy-in and leadership among oncologists, according to David Miller, MD, MPH, a urologic surgeon and health services researcher at the University of Michigan, Ann Arbor. He addressed this topic during the recent annual meeting of the American Society of Clinical Oncologists.
Read Article
Page 4 of 6
1
2
3
4
5
6
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma